[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence SPRY|EPS -$0.61 vs -$0.51 est (-19.6%)|Rev $22.7M|Net Loss $60.6M ARS Pharmaceuticals, Inc. reported a wider-than-expected loss for Q1 2026 as the biopharmaceutical company continued investing heavily in commercializing its severe allergic reaction treatment.…
[ad_1] Image source: Getty Images To say Greggs‘ (LSE:GRG) shares have been lukewarm in recent years would be an understatement. Down 40% in the past 36 months, this FTSE 250 stock has served up returns best described as a soggy…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence NIQ|EPS $0.15 vs $0.10 est (+50.0%)|Rev $1.07B|Net Loss $90.1M Q2 EPS guidance — adjusted $0.19 – $0.21|Stock $10.04 (-2.5%) EPS YoY +130.6%|Rev YoY +11.1%|Net Margin -8.4% NIQ Global Intelligence (NIQ) delivered a commanding…
[ad_1] Image source: Getty Images Using a Stocks and Shares ISA to earn passive income streams thanks to dividends is a relatively simple approach to try and earn some extra money without working for it. It does involve risks, like…
[ad_1] Leslie’s (NASDAQ: LESL) is trending because its fiscal second-quarter report finally gave investors some evidence that the company’s turnaround plan may be producing real operating traction. Sales, comparable sales, customer counts, and gross margin all improved in the quarter,…
[ad_1] Image source: Getty Images The Legal & General (LSE: LGEN) dividend yield is a thing of beauty, but the share price? Not so much. Today, the blue-chip insurer and asset manager boasts a magnificent trailing dividend yield of 8.8%,…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence LIEN|EPS $0.44 vs $0.36 est (+22.2%)|Net Investment Income $10.0M Stock $9.07 (+0.0%) Strong Beat. Chicago Atlantic BDC, Inc. (NASDAQ: LIEN) reported Q1 2026 net investment income per share of $0.44, comfortably exceeding the…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence EGAN|EPS $0.11 vs $0.07 est (+57.1%)|Rev $22.5M|Net Income $2.4M eGain Corporation (EGAN) posted Q3 2026 non-GAAP EPS of $0.11, topping Wall Street’s $0.07 estimate (beat by 57.1%). The company generated $22.5M in revenue…
[ad_1] Image source: Getty Images Every time I think the BT (LSE: BT.A) share price has gone as high as it can, it forces me to think again. I now view it as one of the FTSE 100’s most impressive…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence DARE|EPS -$0.20 vs -$0.30 est (+33.3%)|Rev $152,455|Net Loss $3.0M Daré Bioscience, Inc. (DARE) posted a Q1 2026 diluted loss of $0.20 per share, narrower than the -$0.30 expected loss (33.3% narrower). The company…